[NEW DATA] Optimizing Lipid Nanoparticles for Enhanced CRISPR/Cas9 Gene Editing in Lung Tumor Cells and Exploring the Potential for Inhalation

Time: 12:00 pm
day: Day 2


  • Exploring innovative therapeutic approaches for persistent global health challenges posed by lung cancer, showcasing the potential of CRISPR/Cas9 LNPs in targeting specific lung tumor genes for gene editing
  • Detailing the screening of formulations, physicochemical characterization, and successful enhancement of gene editing efficiency targeting a specific lung cancer mutation
  • Exploring the potential of CRISPR/Cas9-LNPs as inhalable formulations for targeting lung cancer and addressing the challenges associated with the preparation and characterization